Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: XL-999
  • Price: $1300.0/250mg $2600.0/1g $700.0/100mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

705946-27-6

705946-27-6 structure
705946-27-6 structure
  • Name: Tyrosine kinase-IN-1
  • Chemical Name: Tyrosine kinase-IN-1
  • CAS Number: 705946-27-6
  • Molecular Formula: C26H28FN5O
  • Molecular Weight: 445.532
  • Catalog: Research Areas Cardiovascular Disease
  • Create Date: 2018-02-17 23:42:32
  • Modify Date: 2024-01-08 16:09:41
  • Tyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor with IC50s of 4, 20, 4, 2 nM for KDR, Flt-1, FGFR1 and PDGFRα, respectively.

Name Tyrosine kinase-IN-1
Synonyms (3Z)-5-[(1-Ethyl-4-piperidinyl)amino]-3-[(3-fluorophenyl)(5-methyl-1H-imidazol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one
2H-Indol-2-one, 5-[(1-ethyl-4-piperidinyl)amino]-3-[(3-fluorophenyl)(5-methyl-1H-imidazol-2-yl)methylene]-1,3-dihydro-, (3Z)-
(3Z)-5-[(1-Ethyl-4-piperidinyl)amino]-3-[(3-fluorophenyl)(4-methyl-1H-imidazol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one
6I7PLF6N8L
Description Tyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor with IC50s of 4, 20, 4, 2 nM for KDR, Flt-1, FGFR1 and PDGFRα, respectively.
Related Catalog
Target

Flt-1:4 nM (IC50)

KDR:20 nM (IC50)

PDGFRα:4 nM (IC50)

FGFR1:2 nM (IC50)

In Vitro Tyrosine kinase-IN-1 is from reference (compound 8K)[1].
In Vivo Tyrosine kinase-IN-1 shows a reasonable PK profile (AUC(0–∞)=1.9, t1/2=4.6 h). It has a favorable oral bioavailability (F=63%) in rats[1].
Kinase Assay Kinase Inhibition Assays Kinase activities of KDR and PDGFRα are measured as the percent of ATP consumed following the kinase reaction using luciferaseluciferin-coupled chemiluminescence. Kinase reactions are initiated by combining test compound (Tyrosine kinase-IN-1), ATP, kinases and substrates in a 20 mL volume using 384-well microtiter plates. For KDR, the final reaction mixture contained 3 mM ATP, 1.6 mM poly(Glu, Tyr) 4:1 and 1.5 nM KDR of residues D807-V1356 with an N-terminal GST tag. For PDGFRα, the final reaction mixture contained 2 mM ATP, 10 mM MBP and 14 nM PDGFRα of residues Q551-L1089 with an N-terminal GST tag. The reaction mixture is incubated at room temperature for 4 h (KDR) or 2 h PDGFRα before a 20 mL aliquot of Kinase Glo is added and luminescence signal is measured using a Victor2 plate reader. Total ATP consumption is limited below 50%[1].
References

[1]. Moon K, et al. The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 22 (2012) 4979–4985

Density 1.3±0.1 g/cm3
Molecular Formula C26H28FN5O
Molecular Weight 445.532
Exact Mass 445.227783
LogP 2.59
Index of Refraction 1.652
Storage condition 2-8℃